Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntibodies, Monoclonal, HumanizedReceptor, erbB-2Antineoplastic AgentsBreast NeoplasmsCombined Modality TherapyTreatment OutcomeAntibodies, MonoclonalCyclophosphamideCisplatinDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalDrug Resistance, NeoplasmPaclitaxelTaxoidsNeoplasm StagingSurvival AnalysisAnthracyclinesDrug Administration SchedulePrognosisSurvival RateEtoposideVinblastineGenes, erbB-2Lung NeoplasmsCarboplatinNeoplasm MetastasisMethotrexateDeoxycytidineNeoplasm Recurrence, LocalCell Line, TumorMaytansineInduction ChemotherapyNeoplasmsIfosfamideAntimetabolites, AntineoplasticBleomycinOrganoplatinum CompoundsOvarian NeoplasmsFollow-Up StudiesSalvage TherapyKaplan-Meier EstimateCarcinoma, Non-Small-Cell LungAntineoplastic Agents, AlkylatingClinical Trials as TopicAdenocarcinomaChemotherapy, Cancer, Regional PerfusionCytarabineAntineoplastic Agents, PhytogenicQuinazolinesNeutropeniaTime FactorsTumor Markers, BiologicalNauseaBrain NeoplasmsTesticular NeoplasmsVomitingTransplantation, AutologousAntibiotics, AntineoplasticInfusions, IntravenousDose-Response Relationship, DrugLymphoma, Non-HodgkinLymphatic MetastasisProspective StudiesRadiotherapy, AdjuvantHodgkin DiseaseBone NeoplasmsXenograft Model Antitumor AssaysDisease ProgressionStomach NeoplasmsColorectal NeoplasmsRadiotherapyGranulocyte Colony-Stimulating FactorLeukopeniaBridged CompoundsDacarbazineNeoplasms, Germ Cell and EmbryonalCarmustineMice, NudePeritoneal NeoplasmsRandomized Controlled Trials as TopicDrug SynergismCarcinomaLomustineLiver NeoplasmsCamptothecinRecurrenceIn Situ Hybridization, FluorescencePlatinum CompoundsImmunohistochemistryInfusions, Intra-ArterialOsteosarcomaClinical Trials, Phase III as TopicMelphalanAntiemeticsMitomycinCentral Nervous System NeoplasmsGene Expression Regulation, Neoplastic